Carol Ann Satler
President chez Respira Therapeutics, Inc.
Profil
Carol Ann Satler is currently the President, Director, and Chief Medical Officer at Respira Therapeutics, Inc. She was previously the President and Chief Executive Officer at Indigo Pharmaceuticals, Inc. She holds a doctorate degree from Case Western Reserve University and an undergraduate degree from Wesleyan University.
Postes actifs de Carol Ann Satler
| Sociétés | Poste | Début |
|---|---|---|
Respira Therapeutics, Inc.
 Respira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Respira Therapeutics, Inc. engages in provision of pulmonary delivery of therapeutics for respiratory diseases. Its technology Dry Powder Inhaler (DPI), deliver dry powder drug products to the lung more effectively than other DPI technologies. The company was founded in 2010 and is headquartered in Albuquerque, NM. | President | - |
Anciens postes connus de Carol Ann Satler
| Sociétés | Poste | Fin |
|---|---|---|
Indigo Pharmaceuticals, Inc.
 Indigo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indigo Pharmaceuticals, Inc. manufactures pharmaceutical products. It mainly focuses on the development of new treatments for cardiovascular diseases, such as peripheral arterial disease. The company was founded in 2007 and is headquartered in New York, NY. | Directeur Général | - |
Formation de Carol Ann Satler
| Case Western Reserve University | Doctorate Degree |
| Wesleyan University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Indigo Pharmaceuticals, Inc.
Indigo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indigo Pharmaceuticals, Inc. manufactures pharmaceutical products. It mainly focuses on the development of new treatments for cardiovascular diseases, such as peripheral arterial disease. The company was founded in 2007 and is headquartered in New York, NY. | Health Technology |
Respira Therapeutics, Inc.
Respira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Respira Therapeutics, Inc. engages in provision of pulmonary delivery of therapeutics for respiratory diseases. Its technology Dry Powder Inhaler (DPI), deliver dry powder drug products to the lung more effectively than other DPI technologies. The company was founded in 2010 and is headquartered in Albuquerque, NM. | Health Technology |